We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® (CT03Ext)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01111383
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : November 21, 2011
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2011
  Study Completion Date : May 2011